
Genotropin Enhances Insulin Sensitivity in American Males with Type 2 Diabetes: 3-Year Study
Reading Time: 2 minutes Introduction Type 2 diabetes represents a significant health challenge in the United States, particularly among males, who face higher risks of associated complications such as cardiovascular disease and renal failure. Insulin sensitivity, a critical factor in managing type 2 diabetes, can be influenced by various therapeutic interventions. Genotropin, a recombinant human growth hormone, has been explored for its potential metabolic benefits. This article presents the findings of a three-year prospective study examining the impact of Genotropin on insulin sensitivity in American males diagnosed with type 2 diabetes. Study Design and Methodology The study enrolled 150 American males aged between 40...